Nicklas Juel Spindler, MD

Immuno-radiotherapy for metastatic castration-resistant prostate cancer

Gitte Persson, Associate Professor, MD, PhD
Dorte Nielsen, Professor, MD, MDSc, PhD
Rikke Løvendahl Eefesen, MD, PhD
Henriette Lindberg, MD, PhD
Thomas Lars Andresen, Professor, M.Sc, PhD


Write to Alice Markussen, MD

Biliary tract cancer: Danish population-based analysis, CAPEOXGEM compared to CISGEM in the 1. line and immune checkpoint inhibition with radiation beyond front line therapy

Julia Sidenius Johansen, Professor, MD, DMSc
Dorte Nielsen, Professor, MD, DMSc
Inna Chen, MD
Ole Larsen, MD, PhD
Linda Kærlev, Associate Professor, MD, PhD

Write to Anne Polk, MD

Cardiotoxicity from 5-Fluorouracil and its oral pro-drugs
Dorte Lisbeth Nielsen, Clinical Professor, MDSc, PhD
Kirsten Vistisen, Senior Consultant Oncologist, MD, PhD
Morten Schou, Senior Consultant Cardiologist, MD, PhD
Merete Vaage-Nilsen, Senior Consultant Cardiologist​​, MD, PhD

Write to Morten Nielsen, MD 

Tumor-Infiltrating Lymphocytes (TILs) based Adoptive Cell Transfer immunotherapy (ACT) for patients with sarcoma

Supervisors: Inge Marie Svane, Chief physician, Clinical Professor
Anders Krarup-Hansen, Chief physician, Associate professor , MD, PhD 
Niels Junker, MD, PhD

Arginase-1 Peptide Vaccine in Patients with Metastatic Solid Tumors

Supervisor: Inge Marie Svane, Chief physician, Clinical Professor

Write to Anders Kverneland, MD

Adoptive cell therapy across cancer diagnoses

Supervisor:  Inge Marie Svane, Chief physician, Clinical Professor
Co-supervisor: Marco Donia, MD, PhD

Personalized cancer immunotherapy using Neoepitope Peptide based Vaccines

Supervisor:  Inge Marie Svane, Chief physician, Clinical Professor

Co-supervisor: Marco Donia, MD, PhD 

Biomarkers in patients with lung cancer – can they provide new information on diagnosis, treatment effect and prognosis

Dorte Nielsen Professor, MD, DMSc 
Stig E. Bojesen Professor, MD, DMSc  

Write to Charlotte Brinch

A prospective study of liquid biopsy, plasma concentration of tyrosine kinase inhibitors and Quality of Life in patients with Gastrointestinal Stromal Tumor (GIST)

Anders Krarup-Hansen, Consultant, MD, Ph.D., Assistant Professor, Department of Oncology, Herlev and Gentofte Hospital.
Estrid Høgdall, Professor, Ph.D., DMSc, Head of Molecular Unit, Department of Pathology, Herlev and Gentofte Hospital, University of Copenhagen. 
Ninna Aggerholm Pedersen, MD, MS.c., Ph.d., Department of Oncology, Aarhus University Hospital.

Write to Marta Kramer Mikkelsen, RN, MHSc

Patient Activation through Counseling, Exercise and Mobilization (PACE-Mobil) among patients with advanced pancreatic, biliary tract and lung cancer

Mary Jarden, associate professor, MScN, PhD
Dorte Nielsen, professor, MD, DMSc
Cecilia Margareta Lund, MD, PhD
Anders Vinther, Senior researcher, PT, PhD

Combined circulating protein biomarkers for early diagnosis and improved prediction of response and prognosis of patients with pancreatic cancer

Julia S. Johansen, Professor, MD, DMSc  
Stig E. Bojesen, Professor, MD, DMSc  
Dorte Nielsen, Professor, MD, DMSc  
Inna Chen, MD